Cargando…
Expression pattern analysis and drug differential sensitivity of cancer-associated fibroblasts in triple-negative breast cancer
Triple-negative breast cancer (TNBC) has the characteristics of a complex molecular landscape, aggressive or high proliferation leading to poor prognosis, and behavioral heterogeneity. The purpose of the present study was to determine the spatiotemporal expression of α-smooth muscle actin (α-SMA)-po...
Autores principales: | Li, Qilong, Li, Mohan, Zheng, Kexin, Tang, Shuang, Ma, Shiliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563008/ https://www.ncbi.nlm.nih.gov/pubmed/33069102 http://dx.doi.org/10.1016/j.tranon.2020.100891 |
Ejemplares similares
-
Identification of Cancer-Associated Fibroblast Subtype of Triple-Negative Breast Cancer
por: Wang, Maoli, et al.
Publicado: (2022) -
Atractylenolide-I Sensitizes Triple-Negative Breast Cancer Cells to Paclitaxel by Blocking CTGF Expression and Fibroblast Activation
por: Wang, Meng, et al.
Publicado: (2021) -
LncRNAs as new biomarkers to differentiate triple negative breast cancer from non-triple negative breast cancer
por: Lv, Mingming, et al.
Publicado: (2016) -
Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer
por: Takai, Ken, et al.
Publicado: (2016) -
EPHB6 augments both development and drug sensitivity of triple-negative breast cancer tumours
por: Toosi, Behzad M., et al.
Publicado: (2018)